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Background: The role of the hospital environment in transmission of ESBL-Klebsiella pneumoniae (ESBL-KP) and
ESBL-Escherichia coli (ESBL-EC) is poorly defined. Recent data however suggest that in the hospital setting, ESBL-KP
is more transmissible than ESBL-EC. We sought therefore to measure the difference in hospital contamination rates
between the two species and to identify key risk factors for contamination of the hospital environment with these
organisms.
Methods: We systematically sampled 8 surfaces in the rooms and bathrooms of adult patients colonized or
infected with ESBL-EC or ESBL-KP throughout their hospital stay. Data were collected on factors potentially affecting
contamination rates. Environmental contamination was defined as recovery of an ESBL-producing organism
matching the source patient’s isolate. Multivariate logistic regression analysis was performed at the level of the patient
visit using generalized estimating equations to identify independent predictors of environmental contamination.
Results: 24 patients (11 with ESBL-KP, 11 ESBL-EC and 2 with both organisms) had 1104 swabs collected during 138
visits. The overall contamination rate was 3.4% (38/1104) and was significantly higher for ESBL-KP than ESBL-EC (5.4%
versus 0.4%; p < 0.0001). After multivariate analysis, environmental contamination was found to be negatively associated
with carbapenem exposure (OR 0.06 [95% CI 0.01-0.61]; p = 0.017) and positively associated with the presence of an
indwelling urinary catheter (OR 6.12 [95% CI 1.23-30.37]; p = 0.027) and ESBL-KP in the source patient (OR 26.23
[95% CI 2.70-254.67]; p = 0.005).
Conclusions: Contamination of the hospital environment with ESBL-producing Enterobacteriaceae (ESBL-E) is inversely
associated with carbapenem exposure. Predictors of hospital contamination with ESBL-E include: indwelling urinary
catheters and ESBL-KP. Rooms of patients with ESBL-KP have substantially higher contamination rates than those with
ESBL-EC. This finding may help explain the apparently higher transmissibility of ESBL-KP in the hospital setting.Background
The prevalence of extended spectrum β-lactamase produ-
cing Enterobacteriaceae (ESBL-E) has increased sharply
over the last decade [1,2]. The reasons for this are complex,
but transmission in healthcare settings is thought to be an
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stated.risk, many hospitals assign colonized or infected patients to
a single room and use gowns and gloves for all patient con-
tact [5]. This approach is based on the assumption that
contamination of clothing and the hospital environment
play an important role in the transmission of ESBL-E spe-
cies [6]. For many healthcare-associated pathogens the de-
gree of hospital surface contamination is closely correlated
with the risk of transmission, but the extent to which this
is true for ESBL-EC and ESBL-KP remains uncertain
[7-9]. Recent studies however do suggest that rates ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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K. pneumoniae (ESBL-KP) than ESBL-E. coli (ESBL-EC)
[10-13]. In light of these observations, we performed a
prospective cohort study to determine whether rates of
contamination of the hospital environment are corres-
pondingly higher for ESBL-KP than ESBL-EC. Secondly,
we recorded a variety of patient factors that could poten-
tially affect contamination rates, in order to identify key
patient and organism factors that affect the risk of hospital
surfaces becoming contaminated with ESBL-E.
Methods
Design, setting and recruitment
Recruitment of patients took place between 13th
November 2012 and 15th January 2013 at Auckland
City Hospital (ACH). ACH is a tertiary level institution
with 700 beds for adult patients. For inclusion in the
study, adult patients admitted to ACH were required
to have ESBL-EC or ESBL-KP recovered from either rectal
swabs or clinical specimens during their hospital stay. Eli-
gible patients were also required to give informed consent
and to be sufficiently mobile to use the bathroom facilities.
According to hospital policy, rectal swabs are collected on
all patients with a history of hospital admission during the
preceding year in order to screen for ESBL-E colonization.
Patients found to be colonized with either ESBL-EC or
ESBL-KP are then managed with contact precautions in a
single room. Patients admitted to the maternity and psy-
chiatric wards as well as intensive care units were ex-
cluded. Those meeting criteria for inclusion were asked to
give informed consent to participate in the study. Partici-
pation involved collection of serial sets of environmental
swabs as well as data on putative risk factors for environ-
mental contamination from the patient records. Envir-
onmental sampling was performed daily on week days
in the morning. Standard hospital cleaning protocols
used throughout the study period consisted of once
daily cleaning of the over bed tables, call bells and bed-
side cabinets with a damp cloth and detergent plus
twice daily cleaning of toilets, basins and high touch
surfaces in the patient bathrooms using 0.1% sodium
hypochlorite solution. Over weekends there was a 3 day
interval between sampling. Cleaning staff were not in-
formed about the study. Sampling continued until pa-
tient discharge. For each patient visit, whether or not
cleaning had occurred previously on the same day was
recorded. Ethics approval for this study was granted by
the Northern Regional Ethics Committee.
Data collection
For each patient admission the following putative risk
factors for environmental contamination were collected
from the clinical records: age and gender of patient; the
use of an indwelling urinary catheter (IDC); the receiptof antibiotics in general as well as the receipt of carba-
penem antibiotics specifically; the Chronic Disease
Score–Infectious Diseases (CDS-ID) score [14]; whether
the patient had at least one documented episode of diar-
rhoea; the specimen site (s) from which ESBL-E were re-
covered during their stay; the clinical service caring for
the patient and whether or not the patient had clinical in-
fection with ESBL-E. At each visit, whether or not the
room had undergone cleaning that day prior to environ-
mental sampling was also recorded. The primary outcome
of interest was environmental contamination with ESBL-E.
Environmental contamination was defined as recovery of
an environmental ESBL-E with the same species and anti-
biotic susceptibility profile as the patient’s isolate.
Environmental sampling
Sampling of the environment was carried out in eight areas
in the patient room and bathroom. An approximate 10 cm
by 10 cm square was sampled with five longitudinal and
five latitudinal strokes of a sterile, nylon tipped flocked
swab (Copan diagnostics, California, USA) pre-moistened
with nutrient broth immediately before use. This was then
placed in 1.5 mL of nutrient broth in sterile containers, and
swirled for 20 seconds. Samples were then vortexed for 2
minutes before being incubated overnight at 35°C. The
eight environmental surfaces sampled were as follows: the
blood pressure cuff; the nurses’ call bell; the top of the pa-
tient’s bedside cabinet; the patient’s over bed tray table; the
toilet seat; the hand rail next to the toilet; the basin tap in
the bathroom and the bathroom’s inside door handle. In
addition to the eight environmental samples, the patient’s
antecubital fossa was also sampled at each visit.Culture methods
After being incubated overnight the nutrient broth sam-
ples were recorded to show either growth or no growth,
based on the presence of a turbid solution. The samples
showing growth were then plated on MacConkey (MAC)
agar and incubated overnight at 35°C. Any colonies on
MAC agar were subcultured to ChromID® ESBL agar (bio-
Merieux, Marcy L’Etoile, France) and incubated overnight
at 35°C. Colonies on chromogenic agar were identified
according to routine laboratory protocols using Matrix
Assisted Laser Desorption/Ionization-Time of Flight,
(MALDI-TOF), mass spectrometry (Vitek MS, bioMer-
ieux). ESBL status was confirmed using the CLSI com-
bined disk diffusion test. Susceptibility testing was
performed using the Vitek II® (bioMerieux) gram negative
susceptibility card AST-N247 against a range of 12 anti-
biotics (meropenem, trimethoprim-sulphamethoxazole,
amoxicillin-clavulanate, ciprofloxacin, norfloxacin, cefoxi-
tin, gentamicin, amikacin, nitrofurantoin, piperacillin-
tazobactam, tobramycin).
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Analysis was performed using each patient visit as a
data point. The dependent variable was recovery from
at least one environmental site of an ESBL-producing
organism with the same species and susceptibility pro-
file as the patient’s isolate. Fisher’s exact and the un-
paired Wilcoxon rank sum test were used to compare
categorical and continuous variables respectively. For
each patient, visits were numbered sequentially. “Visit
number” was included in the analysis as a continuous
variable to determine whether the probability of de-
tecting contamination changed with successive visits.
Significant patient and organism factors on univariate
analysis were included in a multivariate model derived
using backward stepwise logistic regression. The multi-
variate model was derived using generalized estimating
equations to control and adjust for the possibility that
outcomes associated with repeated visits to individual
patients may not have been independent. The signifi-
cance of individual predictors during fitting of the
model was assessed using the Wald statistic. All testing
was two tailed and statistical significance was defined as




Between 13th November 2012 and 15th January 2013,
24 of 46 (52%) eligible patients gave informed consent
to participate in the study. The remaining 22 patients
either declined to participate, or were discharged prior
to obtaining consent, or were unable to give informed
consent due to impaired cognition or language bar-
riers. For the 24 participating patients (11 with ESBL-
EC, 11 with ESBL-KP and 2 patients co-colonized with
both organisms), 1104 environmental swabs were col-
lected during a total of 138 visits. Of the 24 partici-
pants, 17 were recruited on the basis of positive rectal
swabs (10 with ESBL-EC, 5 with ESBL-KP and two
with both species) and 7 were recruited on the basis of
a positive clinical specimen (6 with ESBL-KP and 1
with ESBL-EC). Positive clinical specimens included
catheter urine specimens from 2 patients; a mid stream
urine from one patient; wound swabs from 3 patients
and one patient with a positive blood culture collected
from a central line. These corresponded to five clinical
infections: two catheter-associated UTIs (one ESBL-
EC, one ESBL-KP); one urinary infection without an
IDC (ESBL-KP); one surgical wound infection (ESBL-
KP) and one central line infection (ESBL-KP). Of the
138 visits; 52 were to patients with ESBL-EC, 81 were
to patients with ESBL-KP and 5 were to patients colonized
with both organisms. Patients were under the care of a
variety of surgical and medical services: cardiothoracicand vascular surgery- 4 patients; general medicine and eld-
erly care- 6; haematology and oncology- 4; respiratory-2;
cardiology-2; and one patient each from neurology, neuro-
surgery, head and neck surgery, renal, urology and ortho-
paedics. No significant associations were observed between
environmental contamination and any particular clinical
service (data not shown).
Rates and distribution of contamination
Overall, the rate of environmental contamination with
ESBL-E was 38/1104 (3.4%). One environmental swab
yielded both organisms from a patient co-colonized
with ESBL-EC and ESBL-KP. There were no cases
where the environmental isolate (s) did not match the
species of the corresponding isolate (s) from the room
occupant. Corresponding isolates also had consistent
antibiotic susceptibility profiles against all 12 antibi-
otics tested. The 38 environmental isolates were ob-
tained from 8 patients during 26/138 visits. Thus, there
were a total of 112 visits where no environmental con-
tamination was detected. There was no obvious rela-
tionship between sites of contamination on consecutive
visits for individual patients (Figure 1). The interval be-
tween consecutive visits was either 1 day during the
week or 3 days over weekends except for an extended
interval (during the New Year period) of 17 days for pa-
tient 4 between visits 19 and 20 (Figure 1). When exam-
ined by environmental site, the rate of environmental
recovery was significantly higher for ESBL-KP than for
ESBL-EC (37/688 [5.4%] versus 2/456 [0.4%] respect-
ively; p < 0.0001 [co-colonized patients included in both
groups]). Similar findings were seen when analysed at
the visit level (Table 1).
The number of samples positive for ESBL at each of the
eight environmental sites plus the antecubital fossa is
shown in Figure 2. Two patients colonized with ESBL-KP
alone had ESBL-KP isolated from the antecubital fossa
during 3 visits for one patient and 1 visit for the other [4/
138 (2.9%)].
Risk factor analysis
Factors associated with environmental contamination
on univariate analysis are shown in Table 1. Along with
a variety of other factors, the “patient identity” of two
patients was associated with environmental contamin-
ation (patients 1 and 4, Figure 1). Patient 1 was a 75
year old male under the care of the vascular surgery
service who had an IDC in place throughout his stay
and had ESBL-KP isolated from a rectal swab only. Pa-
tient 4 was an 86 year old male under the care of the
head and neck surgery service with no IDC and ESBL-
KP isolated from a surgical scalp wound but was not
thought to be causing clinical infection. A negative associ-
ation was observed with antibiotic use in general as well





























Figure 1 Time line of visits for the 8 patients with at least one positive environmental swab. Figure 1 Legend: Rows 1–8 represent
patients with at least one positive environmental sample. Columns 1–25 indicate visit number. Blank cells represent visits for which no
environmental contamination was detected. BT = Basin tap, TS = Toilet seat, DH = Bathroom door handle, AC = Antecubital fossa, CB = Call bell,
NT = Nightingale (over bed) table, BC = Bedside cabinet, BH = bathroom handrail. *Patient 2 was colonized with ESBL-EC alone and patient 8 was
colonized with both ESBL-EC and ESBL-KP. The remaining patients were colonized with ESBL-KP alone.
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tween environmental contamination and clinical infection
due to ESBL-E was also observed. Three of the five pa-
tients with clinical infection received treatment with a
carbapenem.
No significant difference between contamination
rates were observed according to whether the patient
was recruited on the basis of a positive clinical speci-
men; or more specifically, whether or not the organism
was isolated from urine or a wound swab. There was
no significant change in the likelihood of contamin-
ation with successive visits. Because of the high level of
co-linearity between clinical infection and carbapenem
exposure, only the latter variable was included in the
multivariate model based on its lower p value on uni-
variate analysis. Variables that remained significantly
associated with environmental contamination in the
final multivariate model were: colonization with ESBL-
KP (Odds ratio [OR] 26.23 [95% confidence interval(CI): 2.70-254.67]; p = 0.005); the use of an IDC in the
source patient (OR 6.12 [95% CI: 1.23-30.37]; p =
0.027) and carbapenem exposure (OR 0.06 [95% CI
0.01-0.61]; p = 0.017) (Table 2). There was also a posi-
tive association with male gender although this was
not quite statistically significant (OR 10.53 [95% CI
0.83-133.56]; p = 0.069).
Discussion
Our findings suggest that patients with ESBL-E are
more likely to contaminate their hospital room with vi-
able ESBL-E if they are colonized or infected with
ESBL-KP rather than ESBL-EC. Moreover, our findings
suggest that this difference between species cannot be
accounted for by corresponding differences between
patient characteristics alone. Even after we adjusted
for a wide range of potential confounding factors by
multivariate analysis, the association between ESBL-
KP and environmental contamination remained highly
Table 1 Univariate analysis comparing 26 visits with environmental contamination with the 112 visits without
environmental contamination
Contaminated (%) Non- contaminated (%) Crude OR (95% CI) P value
Room cleaned 3/26 (11.5) 20/112 (17.9) 0.60 (0.13–2.40) 0.57
Median visit number (IQR) 3 (1–9) 4 (2–8) – 0.59
ESBL-KP 25/26 (96.2) 61/112 (54.5) 20.90 (2.85–428.64) <0.0001
CDS-ID≥ 1 22/26 (84.6) 86/112 (76.8) 1.66 (0.48–6.29) 0.44
Median age (IQR) 75 (62–86) 66 (48–81) – 0.05
Male patient 22/26 (84.6) 51/112 (45.5) 6.58 (1.97–24.24 <0.0001
Patient 4 10/26 (38.5) 15/112 (13.4) 4.04 (1.40–11.72) 0.008
Patient 1 6/26 (23.1) 0/112 (0) – <0.0001
Antibiotic exposure 11/26 (42.3) 79/112 (70.5) 0.31 (0.12–0.80) 0.01
Carbapenem exposure 3/26 (11.5) 40/112 (35.7) 0.24 (0.05–0.90) 0.02
IDC 14/26 (53.8) 26/112 (23.2) 3.86 (1.46–10.29) 0.003
Diarrhoea 8/26 (30.8) 12/112 (10.7) 3.70 (1.18–11.58) 0.025
Clinical specimen ESBL-E 14/26 (53.8) 51/112 (45.5) 1.40 (0.55–3.56) 0.52
Clinical infection 3/26 (11.5) 34/112 (30.4) 0.30 (0.07–1.15) 0.05
Isolation from wound swab 12/26 (46.2) 33/112 (29.5) 2.05 (0.79–5.34) 0.11
Isolation from urine 2/26 (7.7) 11/112 (9.8) 0.77 (0.11–4.05) 1.0
“IQR” = interquartile range; “Clinical Specimen ESBL-E” = at least one positive clinical specimen culture positive with ESBL-E.
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that intrinsic biological differences between E. coli and
K. pneumoniae affect their capacity to remain viable in
the environment; a conclusion for which there is at
least some supportive data [15,16]. Another possibility
is that the particular cleaning practices at our hospital
had a lesser impact on ESBL-KP than ESBL-EC al-
though this possibility is undermined by the similarity
between our findings and those of a recent study per-
formed in a pediatric hospital in France [17]. In that
study also, ESBL-KP remained a significant risk factor

































Figure 2 Relative rates of contamination across the different sites samfor host factors by multivariate analysis. Similar find-
ings have also been reported by investigators from
another French hospital [18]. It appears therefore that
differences in hospital contamination rates between
the two species are consistent between different geo-
graphic regions, between different patient groups and
between different hospitals with different cleaning
practices. When taken together therefore, these find-
ings may potentially help to explain the growing body
of evidence indicating that in the hospital setting,
ESBL-KP has greater transmission potential than
ESBL-EC [10-13].ation with ESBL-E by environmental site








Table 2 Factors remaining significantly associated with
environmental contamination in the multivariate model
Adjusted OR (95% CI) P value
ESBL-KP 26.23 (2.70–254.67) 0.005
Indwelling urinary catheter 6.12 (1.23–30.37) 0.027
Carbapenem exposure 0.06 (0.01–0.61) 0.017
ESBL-KP = ESBL-Klebsiella pneumoniae (Referenced to ESBL-Escherichia coli).
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the source patient. Firstly, we found the association be-
tween environmental contamination and the source
patient having an indwelling urinary catheter (IDC)
remained significant after multivariate analysis. This
finding suggests that urinary catheters can play an im-
portant role in facilitating environmental contamination
and that this association is independent of the patient
having a catheter associated urinary tract infection.
More work is needed to corroborate this finding but on
a practical level, this finding reinforces the importance
of programs to reduce unnecessary IDC use and to en-
sure their removal at the earliest opportunity [19].
We also observed an association between male gen-
der and environmental contamination that trended to-
wards significance in the final multivariate model;
possibly reflecting gender-based differences in hygiene
practices. Of note, male gender has been reported to
be an independent risk factor for both ESBL-infection
and colonization in several previous studies [20-22].
We also found that patients exposed to antibiotics
(and more specifically carbapenems) had lower rates of
contamination. This suggests that some antibiotics
such as carbapenems with activity against ESBL-E may
reduce bacterial load of the organism as has been re-
ported previously for VRE [23]. It seems very likely
that the negative association we observed between en-
vironmental contamination and clinical infection is
also explained by the same mechanism.
In keeping with the French pediatric study, prior
cleaning did not appear to have a significant effect on
contamination rates, perhaps because cleaning was in-
adequate and/or there was a tendency for contamin-
ation to reoccur rapidly between cleans. High rates of
contamination were found on call bells and over bed
tables in keeping with reports that some of the most
heavily contaminated surfaces are those closest to the
patient bed [24,25].
Our study has both strengths and weaknesses that de-
serve discussion. Firstly, although we were able to dir-
ectly compare rates of contamination between ESBL-EC
and ESBL-KP, we could not assess the risk of transmis-
sion posed by the levels of contamination we detected.
Secondly the number of visits for each patient was notuniform. However on multivariate analysis, we found no
significant relationship between contamination and any
particular patient, indicating that these factors were less
predictive than others we investigated. Thirdly, we did
not collect data on possible differences in adherence to
standard cleaning protocols between wards. Finally, we
did not perform molecular typing to conclusively estab-
lish that the environmental isolates and plasmids were
identical to those from the patient. However, the corre-
sponding species and extensive antimicrobial suscepti-
bility profiles were consistent between corresponding
patient and environmental isolates without exception.
The strengths of the study include the large number
of environmental samples; the longitudinal sampling
(allowing assessment of change in risk of contamination
over time); the assessment of the relative importance of
both patient and organism risk factors; the range of
relevant risk factors that were investigated and the
current lack of published data on factors predisposing
to environmental contamination with ESBL-E.Conclusions
Hospital environmental contamination rates are substan-
tially higher for patients with ESBL-KP compared to
those with ESBL-EC. This observation may help explain
corresponding differences in transmission rates between
the two organisms. Patients receiving carbapenems have
reduced contamination rates whereas indwelling urinary
catheters increase the likelihood of the hospital environ-
ment becoming contaminated with ESBL-E. Further stud-
ies are needed to confirm the external validity of our
findings. Improved understanding of the important mech-
anisms by which ESBL-E transmit between patients in the
hospital setting will provide an opportunity to develop
new strategies to prevent their transmission.
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